Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.
about
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studiesPleiotropic Effects of Metformin on Cancer
P2860
Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Meta-analysis of studies using ...... cer risk in diabetic patients.
@ast
Meta-analysis of studies using ...... cer risk in diabetic patients.
@en
type
label
Meta-analysis of studies using ...... cer risk in diabetic patients.
@ast
Meta-analysis of studies using ...... cer risk in diabetic patients.
@en
prefLabel
Meta-analysis of studies using ...... cer risk in diabetic patients.
@ast
Meta-analysis of studies using ...... cer risk in diabetic patients.
@en
P2093
P2860
P31
P921
P1433
P1476
Meta-analysis of studies using ...... cer risk in diabetic patients.
@en
P2093
Hongzhuan Tan
Pengcheng Zhou
Shujuan Ma
Yanni Xiao
Yixiang Zheng
P2860
P356
10.1097/MD.0000000000006888
P407
P5008
P577
2017-05-01T00:00:00Z